コンテンツへスキップ
Merck

920P

Sigma-Aldrich

Trilogy®

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
12352200
NACRES:
NA.24

形状

aqueous solution

品質水準

包装

pkg of 1 L ready to use (920P-09)
pkg of 1 gal ready to use (920P-10)
pkg of 200 mL 20x (920P-06)
pkg of 200 mL ready to use (920P-05)
pkg of 240 mL 100x (920P-07)
pkg of 50 mL 20x (920P-04)

テクニック

immunohistochemistry: suitable

輸送温度

ambient

詳細

Trilogy is the ultimate solution for your lab. Unlike other EDTA solutions, Trilogy is a near neutral pH solution, making it less harmful on tissue, while still exhibiting the strong unmasking abilities of a conventional EDTA solution. Trilogy′s revolutionary formula combines deparaffinization, rehydration, and unmasking, all in one simple step! Trilogy allows for standardization of the pretreatment procedure, which in turn leads to more consistent and reliable results.

物理的形状

Solution containing pretreatment reagents

その他情報

For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com

法的情報

Trilogy is a registered trademark of Merck KGaA, Darmstadt, Germany

試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

この製品を見ている人はこちらもチェック

Amanda Linkous et al.
Cell reports, 26(12), 3203-3211 (2019-03-21)
The prognosis of patients with glioblastoma (GBM) remains dismal, with a median survival of approximately 15 months. Current preclinical GBM models are limited by the lack of a "normal" human microenvironment and the inability of many tumor cell lines to accurately reproduce
Pamungkas Bagus Satriyo et al.
Journal of clinical medicine, 8(2) (2019-01-30)
Cancer stem cells (CSCs) promote tumor progression and distant metastasis in breast cancer. Cadherin 11 (CDH11) is overexpressed in invasive breast cancer cells and implicated in distant bone metastases in several cancers. The WNT signalling pathway regulates CSC activity. Growing
Allison R Pine et al.
Cancer discovery, 10(7), 964-979 (2020-04-08)
Glioblastoma (GBM), an incurable tumor, remains difficult to model and more importantly to treat due to its genetic/epigenetic heterogeneity and plasticity across cellular states. The ability of current tumor models to recapitulate the cellular states found in primary tumors remains

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)